Qiming Venture Partners
Qiming Venture Partners is a venture capital firm investing in the TMT and healthcare industries at the early and growth stages.
Business Model:
Revenue: $8.1M
Employees: 2-10
Rankings
Industries / Tags:
Detailed Qiming Venture Partners Information
Geographic Data
Address: Room3906 Jinmao Tower
City: Shanghai
State: shanghai municipality
Zip: 200121
Country: CN
Financial Info
Stage:
Raised Last:
$0
Raised Total:$9B
Social
Facebook
Twitter
Linkedin
Crunchbase
Metrics
2,312,265Website Global Rank
8,132Website Monthly Traffic
Twitter Followers
Description
Qiming Venture Partners is a venture capital firm that specializes in building new companies in China. Since their establishment, they have been investing in the TMT and healthcare industries at the early and growing stages. Founded in 2006 by Gary Rieschel, Qiming Venture Partners based in Shanghai, Shanghai.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 4/2017 | ByteDance | Series D | 1B |
| 12/2020 | dMed | Series C | 100M |
| 12/2016 | dMed | Series A | 8M |
| 7/2021 | Hochuen Medical Technology | Series A | 6.2M |
| 1/2012 | MOGU | Series B | 10M |
| 10/2012 | MOGU | Series C | - |
| 4/2018 | ZD Medical | Series A | 16.7M |
| 4/2017 | ZappRx | Series B | 25M |
| 11/2021 | Genlight | Series B | 31.4M |
| 7/2018 | The Good Stuff | Series B | 50M |
| 8/2014 | Lagou | Series B | 25M |
| 11/2010 | Docin | Series B | - |
| 12/2015 | Aerospace Environment | Series A | 1.3M |
| 10/2021 | Brise Pharma | Angel Round | 0 |
| 12/2008 | Docin | Series A | 1M |
| 6/2019 | Pulsar Technology | Series A | - |
| 12/2019 | Chaodian Culture | Series B | 150M |
| 6/2017 | Chaitin Tech | Series A | 4M |
| 1/2020 | Sunny Dental | Series A | 28.7M |
| 6/2015 | Financial Information Management | Series A | 6M |
| 12/2016 | CETA | Series A | 4.4M |
| 12/2018 | Chaodian Culture | Series A | 5.5M |
| 3/2018 | Bouffalo Lab | Series A | 7M |
| 9/2013 | Tiangua Online | Series B | 1M |
| 3/2016 | CashBUS | Series B | 25M |
| 10/2017 | Castbox | Series A | 12.8M |
| 8/2020 | Shukun Technology | Series B | 0 |
| 4/2021 | Xizi Education | Series A | 22M |
| 1/2018 | Innostic | Series A | 39.5M |
| 10/2015 | JFK Biotech | Angel Round | 472.7k |
| 5/2021 | Just Medical | Series B | 34M |
| 8/2019 | Bondent Technology | Series D | - |
| 3/2021 | Fucunbao | Series C | 11.4M |
| 12/2009 | CITIC Pharmaceutical | Series D | 1M |
| 6/2020 | Shukun Technology | Series B | 0 |
| 6/2018 | RENS Energy | Angel Round | 1M |
| 9/2021 | GYENNO Technologies | Series B | 17.3M |
| 2/2015 | Aerospace Environment | Series A | - |
| 7/2017 | Kuaile Zhihui | Series A | 0 |
| 1/2015 | Transwarp | Series A | 5.1M |
| 6/2022 | LaNova Medicines | Series B | - |
| 4/2020 | New Horizon Health | Series D | 20M |
| 2/2016 | Transwarp | Series B | 23.6M |
| 11/2020 | Kira Pharmaceuticals | Venture Round | - |
| 11/2021 | Suci Technology | Series A | 8.3M |
| 3/2015 | Ark Biosciences | Series A | - |
| 10/2016 | APT Medical | Series A | 3.6M |
| 8/2019 | APT Medical | Venture Round | 27.2M |
| 11/2018 | APT Medical | Series C | 19.2M |
| 9/2019 | Yunyinggu | Series C | 22M |
| 10/2012 | CooTek | Series B | 8.2M |
| 6/2021 | Insilico Medicine | Series C | 0 |
| 6/2011 | Domob | Series B | 20M |
| 12/2015 | Nurotron Biotechnology | Series C | - |
| 11/2021 | Shanzhen | Series D | 17M |
| 4/2018 | Castbox | Series B | 13.5M |
| 4/2020 | Yunyinggu | Series C | 28.2M |
| 4/2020 | Chuhang Tech | Series A | 6.4M |
| 10/2015 | Luoji Siwei | Series B | - |
| 5/2021 | Hope Medicine | Series B | 56M |
| 4/2021 | Sincere Edu | Series A | 13M |
| 5/2022 | AskGene Pharma | Series A | 20M |
| 9/2019 | Shanzhen | Series D | 30M |
| 12/2018 | YI Technology | Venture Round | 10M |
| 7/2016 | UBTech Robotics | Series B | 100M |
| 4/2015 | UBTech Robotics | Series A | - |
| 7/2020 | TUNGEE | Series B | 17.2M |
| 4/2012 | Dang Le | Series B | 20M |
| 11/2020 | Nice Tuan | Series C | 0 |
| 5/2011 | Crown Bioscience | Venture Round | 1M |
| 11/2021 | Atom Semiconductor | Venture Round | 12M |
| 5/2015 | MedSci | Series A | 14.9M |
| 6/2017 | Meituan Bike | Series E | 600M |
| 3/2020 | NVX Clouds Tech | Series A | 3.9M |
| 8/2018 | Chaodian Culture | Angel Round | - |
| 4/2020 | Pratilipi | Series C | 0 |
| 4/2018 | Miaoshou Doctor | Series C | 79.6M |
| 8/2019 | Webuy Group | Series C | 100M |
| 11/2020 | ZEGOCLOUD | Venture Round | 50M |
| 1/2021 | Yunji Technology | Series C | 0 |
| 1/2017 | Meituan Bike | Series D | 215M |
| 2/2022 | BUD | Series A | 15M |
| 4/2022 | Onechip Bioelectronics | Series B | 23.5M |
| 9/2018 | Tuhu | Series E | 0 |
| 9/2016 | Meituan Bike | Series C | - |
| 5/2015 | Tongdun Technology | Series B | 30M |
| 3/2021 | Hangzhou Weier | Series B | 15.5M |
| 1/2012 | Timesafer | Series A | - |
| 4/2007 | ChinaCache | Series B | 31.5M |
| 12/2009 | ChinaCache | Series D | - |
| 5/2019 | Chuhang Tech | Series A | 4.5M |
| 3/2016 | SharpSpring | Post-IPO Equity | - |
| 4/2021 | Tasogare | Series B | 41.1M |
| 9/2015 | Roborock | Angel Round | - |
| 8/2017 | ARMO BioSciences | Series C | 0 |
| 12/2017 | Mafengwo | Series D | 133M |
| 11/2021 | Zeen Health | Venture Round | 6.3M |
| 5/2021 | TUNGEE | Venture Round | 148M |
| 3/2007 | PPS | Series B | 10M |
| 4/2018 | Chaodian Culture | Series A | 12.6M |
| 6/2007 | ICE Entertainment | Series A | 8.5M |
| 12/2013 | Nurotron Biotechnology | Series C | 16.2M |
| 6/2020 | OriginCell | Series A | 8.4M |
| 7/2018 | AI Prime | Angel Round | 1M |
| 7/2022 | Biotree | Series A | 13.3M |
| 3/2021 | Newsoara | Series C | 7M |
| 5/2019 | New Horizon Health | Series C | 0 |
| 7/2018 | Core Medical | Series A | 4.4M |
| 10/2018 | Akulaku | Series C | 0 |
| 12/2016 | Cencorp Automation | Series A | 10.5M |
| 7/2012 | Beijing Centre Biology | Series B | 2.6M |
| 10/2019 | Casela | Series A | 16.7M |
| 6/2020 | Biren Technology | Series A | 0 |
| 3/2021 | Medilink Therapeutics | Series A | 50M |
| 11/2021 | Tripod Preclinical Research Laboratories | Venture Round | 0 |
| 1/2022 | Deep View Technology | Series B | - |
| 9/2022 | Supervision Technology | Seed Round | - |
| 4/2016 | FraudMetrix | Series C | - |
| 6/2015 | Shenogen Pharma Group | Series D | 2.1M |
| 12/2019 | DiNovA Medtech | Series C | 24.6M |
| 11/2019 | Liuyi Jiaoyu | Series B | 0 |
| 7/2022 | CIX Technology | Seed Round | - |
| 5/2019 | LetsGetChecked | Series B | 0 |
| 5/2017 | Jisuyun | Series A | 7.4M |
| 5/2021 | Yidao Biotechnology | Series C | 61.8M |
| 3/2019 | Insta360 | Series C | 0 |
| 9/2021 | XSKY Data Technology | Series E | 0 |
| 3/2021 | Delta Medical | Series E | 20.1M |
| 8/2019 | Delta Medical | Series C | 7.1M |
| 9/2019 | Insilico Medicine | Series B | 37M |
| 6/2020 | Kingsware | Series A | 14.7M |
| 5/2022 | Point One | Series B | 36.8M |
| 6/2016 | AIQI Technology | Venture Round | 7M |
| 7/2021 | Liangyihui | Series C | 55.9M |
| 11/2019 | Nice Tuan | Series B | 60.4M |
| 8/2015 | Linjia.me | Series B | - |
| 4/2012 | ITutorGroup | Series A | 15M |
| 12/2016 | ANXIN | Series B | 42.7M |
| 10/2021 | Cubenergy Technology | Series A | - |
| 3/2021 | YUANBAO TECH | Series C | 80M |
| 8/2012 | CooTek | Series A | 4.2M |
| 2/2021 | Plum | Series B | 9.1M |
| 12/2021 | Gemsouls | Series A | 4M |
| 1/2021 | Erwan Technology | Series D | - |
| 1/2022 | MKSEMI | Pre-Series A | 12.8M |
| 8/2019 | Huimei Technology | Series C | 30M |
| 12/2014 | LanzaTech | Series D | 0 |
| 11/2013 | LanzaTech | Series C | 0 |
| 5/2015 | Coohua | Series B | 20M |
| 8/2021 | WeRide | Secondary Market | 2M |
| 5/2017 | CANbridge Pharmaceuticals | Series B | 25M |
| 8/2017 | ABC Fintech | Series A | 30M |
| 7/2015 | Bilibili | Series C | 161.4M |
| 10/2016 | Bondent Technology | Series A | 9M |
| 3/2021 | MediLink-Global | Series A | 36.9M |
| 3/2020 | Berry Oncology | Series A | 10M |
| 10/2013 | Unisound | Series A | 16.3M |
| 1/2021 | Cornerstone Robotics | Series A | 17M |
| 9/2007 | Gaoxing Co., Ltd | Series A | - |
| 3/2021 | Casela | Series A | 2.8M |
| 12/2021 | PoPop World | Seed Round | 0 |
| 1/2015 | APUS Group | Series B | 100M |
| 1/2020 | DST Car | Series C | - |
| 2/2022 | Purui | Seed Round | 15.7M |
| 8/2010 | BTR | Series A | 1.6M |
| 11/2006 | Kuwo Science and Technology | Series A | 5.5M |
| 5/2011 | Gan &a; Lee Pharmaceutical | Series B | 30.2M |
| 4/2021 | ZSHK Laboratories | Series A | 15.5M |
| 2/2012 | Gan &a; Lee Pharmaceutical | Series B | - |
| 6/2013 | Venus MedTech | Series A | 17M |
| 9/2017 | Zaojiu | Series A | 5.2M |
| 3/2018 | Zaojiu | Series A | 4.7M |
| 12/2019 | Woof | Series A | 7M |
| 12/2018 | Woof | Series A | 5.8M |
| 5/2014 | VINNO Technology | Series B | 7.7M |
| 8/2018 | CureGenetics | Series A | 17M |
| 1/2019 | V Light | Series A | 2.5M |
| 9/2021 | V Light | Series A | 7M |
| 4/2017 | Bomming Vision | Series A | 4.4M |
| 1/2018 | Bomming Vision | Series A | 1.5M |
| 5/2018 | Tisenc | Series A | 6.3M |
| 3/2005 | b2c.cn | Series A | 3M |
| 6/2009 | Taomee | Series A | - |
| 2/2023 | Hochuen Medical Technology | Series B | - |
| 12/2007 | Topone | Series C | 50M |
| 10/2014 | Coohua | Series A | 4.9M |
| 5/2018 | Philm | Series B | 7M |
| 5/2017 | ET Healthcare | Venture Round | 7M |
| 9/2021 | PlusLife Biotech | Series A | 14.9M |
| 7/2021 | NEIWAI | Series D | 100M |
| 10/2019 | NEIWAI | Series C | 18M |
| 1/2007 | Tianyuan Bio-Pharmaceutical | Series A | - |
| 3/2013 | JHT TCM Clinics | Series A | 2.2M |
| 10/2018 | WeRide | Series A | - |
| 3/2015 | BBI Life Sciences | Post-IPO Equity | 10.3M |
| 2/2015 | Helijia | Series C | 50M |
| 8/2022 | Insilico Medicine | Series D | 35M |
| 4/2015 | Zai Lab | Series A | 18.3M |
| 3/2019 | Gohoo | Series A | 10.6M |
| 11/2015 | Zhihu | Series C | 55M |
| 9/2019 | QwikMatch | Debt Financing | 1.4M |
| 1/2017 | CooTek | Series D | 66M |
| 8/2013 | LP Amina | Series C | 20M |
| 11/2019 | 61Draw.com | Series B | 11M |
| 1/2023 | Insyce | Series B | 21.8M |
| 1/2017 | Bondent Technology | Series B | - |
| 2/2008 | Ether Optronics (Suzhou) Co., Ltd. | Venture Round | - |
| 1/2021 | Erwan Technology | Series E | - |
| 9/2017 | SinoVision Technologies | Series B | 29M |
| 8/2019 | TUNGEE | Series B | 17.7M |
| 2/2014 | VANCL | Series G | 100M |
| 10/2019 | Club Factory | Series D | 100M |
| 7/2017 | Qiagen Suzhou Translational Medicine | Series A | 0 |
| 7/2015 | OneAPM | Series C | 26.7M |
| 11/2021 | Cornerstone Robotics | Series B | 0 |
| 6/2019 | 61Draw.com | Series B | 28M |
| 5/2022 | Yike Polymers | Series B | - |
| 3/2018 | Infervision | Series B | 47.4M |
| 7/2018 | Lanjinrong | Series C | 11.6M |
| 9/2021 | Alamar Biosciences | Series B | 80M |
| 1/2015 | Mitralign | Series E | 23M |
| 12/2021 | Wholee | Series B | 69M |
| 2/2022 | NFTGo | Pre-Series A | 6.8M |
| 6/2018 | IDsManager | Series A | 7.8M |
| 5/2021 | Insight Lifetech | Secondary Market | 18.1M |
| 5/2020 | Nice Tuan | Series C | 0 |
| 2/2013 | Tujia | Series B | 40M |
| 1/2022 | Axera | Series A | 0 |
| 11/2018 | Chushou | Venture Round | 8.4M |
| 1/2018 | Bingobox | Series B | 0 |
| 7/2017 | Bingobox | Series A | 14.7M |
| 1/2017 | Chushou | Series C | 57.6M |
| 9/2016 | Zuiyou | Series B | 53M |
| 5/2013 | CSD E.P. Water Service | Series B | - |
| 6/2008 | LP Amina | Series A | 5M |
| 4/2022 | LTZ Therapeutics | Pre-Series A | 17M |
| 9/2017 | Lagou | Series D | 119.2M |
| 11/2018 | Chomp Cloud | Series B | 13.3M |
| 9/2019 | Platelet BioGenesis | Series A | 26M |
| 5/2022 | Ashermed | Series B | - |
| 5/2020 | Microtech Medical | Venture Round | 20M |
| 6/2015 | Zhejiang JFK | Angel Round | - |
| 4/2014 | Laguo | Series A | 5M |
| 4/2021 | ET Healthcare | Series G | 105M |
| 6/2014 | Zhihu | Series B | 22M |
| 1/2023 | Tingsheng Technology | Series B | 14.7M |
| 9/2020 | Delta Medical | Series D | - |
| 10/2018 | DST Car | Series B | 43.1M |
| 8/2014 | Zai Lab | Series A | 10M |
| 5/2009 | Touchmedia | Series B | 16.2M |
| 10/2017 | WeRide | Seed Round | - |
| 7/2014 | Beijing Richen-Force Science &a; Technology | Series B | 4.5M |
| 12/2021 | Xinchuangyuan Semiconductor | Series A | 75.4M |
| 12/2021 | Yunji Technology | Venture Round | 72.2M |
| 3/2020 | Berry Genomics | Post-IPO Equity | 10M |
| 5/2021 | Wonderful | Secondary Market | 1.4M |
| 7/2017 | AFU | Series C | 9.3M |
| 4/2020 | Shulan Health | Series C | 8.5M |
| 8/2017 | SceneRay | Series C | 19.1M |
| 9/2018 | ET Healthcare | Series C | 17.5M |
| 8/2016 | Xiaoman Technology | Series B | 5.3M |
| 6/2018 | Alpha Biopharma | Series A | 37M |
| 9/2017 | Infervision | Series B | 18.2M |
| 10/2021 | Qingflow | Series B | 11.8M |
| 12/2015 | UBTech Robotics | Series A | 20M |
| 12/2017 | Eigen | Series B | 18.5M |
| 1/2008 | Crown Bioscience | Venture Round | - |
| 9/2019 | DST Car | Venture Round | 30M |
| 12/2019 | Vongi | Series B | 2.9M |
| 4/2018 | Bondent Technology | Series C | 12.7M |
| 8/2010 | 2Duche | Venture Round | - |
| 9/2018 | Bion Interactive Entertainment Company | Seed Round | 2M |
| 3/2008 | Crown Bioscience | Series B | 3.2M |
| 8/2018 | PangQiu | Series A | 6.1M |
| 3/2018 | Frontage Laboratories | Funding Round | 32.4M |
| 3/2020 | IntoCare | Series C | 7M |
| 5/2017 | XSKY Data Technology | Series B | 17.4M |
| 1/2018 | Berry Genomics | Post-IPO Equity | 122.7M |
| 6/2013 | Iron Armour | Series A | 5M |
| 8/2021 | Houmo.AI | Seed Round | 46M |
| 3/2020 | CureGenetics | Series A | 9.5M |
| 11/2007 | Dining Secretary | Series B | - |
| 1/2012 | Qiniu | Series A | - |
| 7/2018 | Zuiyou | Series C | 22M |
| 3/2021 | Zhenge Biotech | Series B | 70M |
| 11/2012 | YPX Cayman Holdings | Series C | 0 |
| 7/2021 | Kingsware | Series B | 42.4M |
| 5/2021 | MKSEMI | Series A | 12.9M |
| 9/2021 | moodytiger | Series B | 20M |
| 7/2016 | Chaitin Tech | Series A | 4.1M |
| 12/2020 | Compart Systems | Venture Round | 398M |
| 1/2014 | Tuhu | Series B | - |
| 8/2018 | CANbridge Pharmaceuticals | Series C | 38.1M |
| 7/2019 | OneAPM | Venture Round | 1.6M |
| 7/2019 | Xiudan | Seed Round | - |
| 1/2019 | Zion Pharma | Series A | 11.9M |
| 8/2020 | Zion Pharma | Series A | 20M |
| 12/2014 | Unisound | Series B | 50M |
| 4/2017 | Berry Genomics | Funding Round | 8.1M |
| 2/2019 | Nuvaira | Equity | 79M |
| 7/2016 | CooTek | Series D | 46M |
| 6/2019 | ZD Medical | Series A | 4.5M |
| 9/2018 | IntoCare | Series B | 3.7M |
| 6/2014 | Inbilin | Series A | 15M |
| 9/2021 | Genevide | Angel Round | 6M |
| 4/2019 | WebComics | Venture Round | 785k |
| 3/2008 | eHi Car Rental | Series A | 5M |
| 7/2015 | CMLabs | Series A | 1.1M |
| 3/2010 | Tigermed | Venture Round | 2M |
| 1/2016 | 8kana | Series A | 6M |
| 9/2006 | Alltech Medical Systems | Series A | - |
| 11/2015 | Shanghai Keysino Separation Technology | Series A | 7.9M |
| 12/2010 | wali | Series A | 4.6M |
| 7/2014 | CooTek | Series C | 69.3M |
| 4/2014 | APT Medical | Series A | - |
| 3/2014 | Domob | Series C | 2M |
| 1/2010 | eHi Car Rental | Series B | 18.7M |
| 4/2019 | Anxin Doctor | Series B | 3.6M |
| 2/2015 | Amoy Diagnostics | Series A | 10.7M |
| 1/2014 | VR Medical | Series A | 5.5M |
| 6/2009 | Alltech Medical Systems | Series B | 5M |
| 5/2017 | Jisuyun | Series A | 7.4M |
| 11/2017 | Kaiheikeji Digital | Series A | 11.5M |
| 1/2011 | CSD E.P. Water Service | Venture Round | - |
| 2/2020 | Fingo | Series A | 7M |
| 4/2017 | Qiang Sen International Community Medical | Series B | 14.6M |
| 9/2017 | Sino Vision | Series B | 30.6M |
| 8/2011 | Arrail Dental Clinic | Series B | 20M |
| 5/2014 | Ants Technology | Series A | 3.5M |
| 3/2016 | Shanghai Rendu Biotechnology | Series B | 2.3M |
| 8/2018 | Jacobio Pharmaceuticals | Series C | 0 |
| 11/2016 | Yinshiji | Series A | - |
| 8/2010 | Jiayuan | Series B | - |
| 10/2018 | DK MedTech | Series B | 8.7M |
| 2/2014 | Wacai.com | Series A | 15M |
| 2/2019 | Xiaobu | Series B | 12M |
| 4/2019 | Bomming Vision | Series A | 596k |
| 7/2016 | KingTrol Data | Series A | 4.5M |
| 3/2016 | SMTP Technology | Series A | 3.1M |
| 1/2015 | Zhaolu Tianxia Wang | Series A | 1.6M |
| 5/2015 | Junhetang | Series B | - |
| 7/2016 | Junhetang | Series B | 7.9M |
| 1/2016 | AIQI Technology | Series A | - |
| 9/2016 | Hypereal | Series B | 10.5M |
| 11/2016 | Chomp Cloud | Series A | 6M |
| 7/2020 | HashQuark | Series A | 2M |
| 3/2011 | CSD Beijing Water Affairs Op | Venture Round | - |
| 6/2014 | Ants Technology | Series B | 7M |
| 6/2009 | ConvenientPower HK | Series A | 3M |
| 1/2018 | Chaodian Culture | Seed Round | 723.8k |
| 9/2014 | Tuhu | Series B | 10M |
| 3/2019 | Emergen | Series B | 29.8M |
| 2/2010 | Aeonmed Medical Treatment | Series A | 3.5M |
| 10/2017 | Moretickets | Series B | 25M |
| 6/2017 | Platelet BioGenesis | Series A | 0 |
| 1/2018 | Roborock | Series B | 3.4M |
| 5/2019 | Mafengwo | Series E | 0 |
| 9/2021 | Sanegene Bio | Series A | 38M |
| 8/2019 | WorkTrans | Series C | 50.5M |
| 2/2020 | Jacobio Pharmaceuticals | Series C | 27M |
| 3/2020 | Wuli Planet | Series A | 7.5M |
| 6/2018 | Wuli Planet | Seed Round | 2M |
| 4/2016 | Roborock | Series B | 25M |
| 9/2011 | Slanissue | Venture Round | 10M |
| 6/2016 | VeeR (Velocious) | Seed Round | 2M |
| 5/2019 | Hesai Technology | Series C | 37M |
| 1/2017 | Connect Biopharmaceuticals | Series A | 20M |
| 8/2022 | Prismlab China Ltd | Series C | 29.1M |
| 7/2018 | Kaiheikeji Digital | Series A | 15M |
| 9/2016 | OneAPM | Series D | 19.5M |
| 4/2016 | CanSinoBIO | Venture Round | 11M |
| 3/2018 | Jisuyun | Series B | 11.4M |
| 7/2017 | Kira Pharmaceuticals | Series A | 5M |
| 12/2009 | Gan &a; Lee Pharmaceutical | Series A | 16.2M |
| 11/2018 | Reelsky Data Systems | Series A | 5.4M |
| 4/2021 | ROX Motor | Series A | 60M |
| 5/2008 | Kuwo Science and Technology | Series B | - |
| 7/2014 | Intelligent Automation | Series B | 4.2M |
| 4/2009 | Kaixin001 | Series B | 20M |
| 1/2008 | PPS | Series C | 20M |
| 8/2008 | VANCL | Series D | 30M |
| 12/2016 | Luo Tianyi | Series B | 8M |
| 12/2018 | FirstGrid | Seed Round | 4.8M |
| 1/2018 | Xiaoman Technology | Series C | 9.7M |
| 4/2016 | Tongdun Technology | Series B | 32M |
| 11/2018 | Haoyiku | Series B | - |
| 4/2021 | Booming Technologies | Series C | 56M |
| 5/2019 | Nice Tuan | Series A | 27.9M |
| 1/2020 | Nice Tuan | Series B | 88.3M |
| 6/2013 | Intelligent Automation | Series A | 5.1M |
| 7/2018 | Wacai.com | Series D | 140M |
| 5/2021 | Health Biotech | Series B | 34.5M |
| 5/2021 | TUNGEE | Series C | 148M |
| 9/2018 | Cubenergy Technology | Series A | 7.3M |
| 3/2015 | CashBUS | Series A | - |
| 4/2021 | Castbox | Series C | 15M |
| 7/2016 | LIH Investment &a; Management | Series A | 12M |
| 5/2017 | Vongi | Series A | 6M |
| 11/2020 | Yunyinggu | Series D | 45.6M |
| 6/2021 | Xiaoe Tech | Series D | 120M |
| 6/2015 | SMTP Technology | Series A | 8.1M |
| 5/2018 | The Makers | Series B | 8.5M |
| 9/2021 | WOWJOY TECHNOLOGY | Series A | 13.6M |
| 3/2022 | ACXEL Tech | Seed Round | 0 |
| 10/2011 | YPX Cayman Holdings | Series B | 20M |
| 3/2013 | Sino MDT | Series A | 4M |
| 5/2018 | Sino Biological | Venture Round | 15.8M |
| 2/2012 | Shanghai Tellgen Life Science | Series A | 5M |
| 12/2017 | Koala Reading | Series A | 10M |
| 2/2022 | WOWJOY TECHNOLOGY | Series A | 10M |
| 3/2020 | Structure Therapeutics | Series A | 26M |
| 3/2018 | Chaonengjie | Seed Round | 2.8M |
| 12/2009 | LP Amina | Series B | 9.4M |
| 7/2014 | MEGVII | Series B | 22M |
| 3/2022 | BlockVision | Seed | 5M |
| 9/2017 | ABC Fintech | Series A | 30M |
| 4/2007 | Jiayuan | Series A | 5.4M |
| 3/2018 | ACEA BIO | Series E | 15M |
| 12/2021 | DP Technology | Series B | 43.7M |
| 8/2018 | Koala Reading | Series B | 20M |
| 8/2014 | Laguo | Series B | 25M |
| 2/2020 | Kira Pharmaceuticals | Series B | 28M |
| 4/2021 | Zion Pharma | Series B | 37M |
| 2/2012 | Touchmedia | Series C | 16.2M |
| 4/2016 | Tiebaobei | Series C | 30.9M |
| 3/2015 | Venus MedTech | Series B | 8M |
| 8/2022 | DeepWay | Series A | 67.2M |
| 9/2017 | Venus MedTech | Series C | 7.4M |
| 7/2022 | Chatail | Series B | 10M |
| 11/2017 | Bioscience | Series C | 15.6M |
| 5/2011 | Crown Bioscience | Series C | 28.8M |
| 2/2021 | Miaoshou Doctor | Series E | 0 |
| 8/2017 | Chomp Cloud | Series A | 7M |
| 5/2022 | BUD | Series B | 0 |
| 6/2012 | Forgame | Private Equity Round | 68.8M |
| 5/2010 | 7k7k.com | Angel Round | 1.1M |
| 12/2017 | Meituan Bike | Corporate Round | - |
| 1/2016 | Zai Lab | Series B | 106.2M |
| 7/2018 | Qingqi Technology | Angel Round | - |
| 5/2010 | Mutto Optronics | Venture Round | - |
| 7/2017 | OPUS | Angel Round | 1M |
| 11/2018 | Guji Information | Angel Round | 287.9k |
| 10/2017 | Jacobio Pharmaceuticals | Venture Round | 19.6M |
| 11/2011 | Leho | Venture Round | 50M |
| 4/2016 | Xueda | Post-IPO Equity | - |
| 4/2007 | Huan Xiong | Venture Round | 1.8M |
| 8/2019 | RedDoorz | Series C | 0 |
| 4/2022 | Clique | Seed Round | - |
| 8/2015 | Tuhu | Series C | 0 |
| 12/2016 | MEGVII | Series C | 100M |
| 3/2016 | Lagou | Series C | 34M |
| 4/2011 | Dazhong Dianping | Series C | 100M |
| 1/2016 | Qiniu | Series D | 100M |
| 12/2019 | KeChow Pharma | Series C | 45M |
| 9/2019 | TigerGraph | Series B | 32M |
| 4/2018 | CMLabs | Series C | 15.9M |
| 7/2021 | Zion Pharma | Series B | 40M |
| 4/2014 | Arrail Dental Clinic | Series C | 70M |
| 10/2020 | Broncus Technologies | Series C | - |
| 4/2018 | Wuxi Vision Pro | Series B | 14.2M |
| 10/2013 | BSC | Series A | 1.6M |
| 10/2014 | WeDoctor | Series B | 106.5M |
| 2/2013 | Qiniu | Series B | 4.2M |
| 4/2019 | Talaris Therapeutics | Series A | 100M |
| 7/2022 | PwnedNoMore | Seed Round | - |
| 12/2017 | QwikMatch | Series B | 6M |
| 1/2022 | CureGenetics | Series B | 0 |
| 6/2020 | Miaoshou Doctor | Series D | 85M |
| 10/2018 | NASN Automotive Electronics | Series A | 14.4M |
| 1/2017 | Microtech Medical | Series B | 12.2M |
| 6/2019 | Liuyi Jiaoyu | Series B | 2.9M |
| 2/2015 | Xueba100.com | Series B | 50M |
| 5/2015 | FraudMetrix | Series B | 30M |
| 6/2018 | WindMIL Therapeutics | Series B | 0 |
| 11/2021 | Allorion Therapeutics | Series A | 0 |
| 1/2017 | Xueba100.com | Series C | 100M |
| 1/2019 | Connect Biopharmaceuticals | Series B | 55M |
| 11/2018 | Cadent Therapeutics | Series B | 40M |
| 10/2018 | CardiaLen | Series B | 17M |
| 12/2014 | Wacai.com | Series B | 50M |
| 8/2021 | Berry Oncology | Series B | 99.2M |
| 10/2008 | Novast | Series B | 50M |
| 7/2019 | Yuanxin Huibao | Series A | 7.3M |
| 10/2020 | Cool Academy | Series A | 15M |
| 4/2019 | Mech-Mind | Series A | 50M |
| 3/2021 | Cool Academy | Series B | 18.9M |
| 6/2017 | MyHealthTeams | Series A | 7.3M |
| 1/2013 | Tuhu | Series A | - |
| 2/2020 | Bouffalo Lab | Series B | 26M |
| 4/2018 | XSKY Data Technology | Series C | 37.8M |
| 6/2014 | Tujia | Series C | 100M |
| 9/2021 | Sunyur | Series B | 0 |
| 10/2007 | Guokang Health Management | Series A | 10M |
| 5/2020 | Alamar Biosciences | Series A | 14M |
| 4/2013 | Shenzhen LETEL Technology | Series A | 5.9M |
| 3/2018 | DST Car | Series A | 47.8M |
| 8/2022 | GluBio Therapeutics | Series A | 22M |
| 7/2021 | Insight Lifetech | Series D | 85M |
| 9/2017 | Hypereal | Series C | 11.8M |
| 12/2020 | Insight Lifetech | Series C | 27.6M |
| 11/2017 | Berry Oncology | Series A | 121.2M |
| 9/2012 | Mafengwo | Series B | 15M |
| 1/2022 | Ceptur Therapeutics | Series A | 0 |
| 6/2018 | Xiaoy Technology | Series B | 4.7M |
| 11/2021 | ROX Motor | Series C | 100M |
| 8/2018 | TUNGEE | Series A | 6.3M |
| 9/2011 | Beijing Centre Biology | Series A | 7.4M |
| 12/2014 | CANbridge Pharmaceuticals | Series A | 10M |
| 9/2011 | Beva | Series A | 3.1M |
| 11/2020 | Asieris Pharmaceuticals | Series D | 0 |
| 8/2018 | Nice Tuan | Seed Round | 0 |
| 1/2017 | Shenogen Pharma Group | Series D | 45M |
| 3/2021 | imToken | Series B | 30M |
| 5/2008 | Oriental Cambridge Education Group | Venture Round | 1M |
| 9/2018 | MicroPoint Bioscience | Series E | 109M |
| 3/2019 | RedDoorz | Series B | 0 |
| 10/2021 | ShouTi | Series B | 0 |
| 9/2015 | Wealth Bridge | Series C | - |
| 8/2011 | Nurotron Biotechnology | Series B | 6.9M |
| 11/2014 | Nurotron Biotechnology | Series C | 1.2M |
| 3/2022 | Medilink Therapeutics | Series B | 70M |
| 8/2014 | Qiniu | Series C | - |
| 12/2018 | Microtech Medical | Series C | 29.1M |
| 4/2021 | SinoUnited Health Clinic | Series C | 30.7M |
| 10/2017 | Bang Er Orthopedic | Series C | 33.9M |
| 6/2019 | Pratilipi | Series B | 15.2M |
| 7/2019 | Dingdong Maicai | Series B | - |
| 1/2023 | Yike Polymers | Series B | - |
| 1/2022 | WoXiaoYa | Series B | - |
| 11/2015 | ET Healthcare | Series B | - |
| 12/2019 | Newsoara | Series B | 22M |
| 6/2017 | Miaoshou Doctor | Series B | 10.9M |
| 5/2019 | SinoUnited Health Clinic | Series B | 9.3M |
| 5/2018 | Heika | Series B | 10.3M |
| 3/2016 | JHT TCM Clinics | Series B | 1.5M |
| 4/2019 | INXX | Series B | 16.5M |
| 3/2018 | Coffee Box | Series B | 88M |
| 6/2016 | CMLabs | Series B | 14.1M |
| 4/2021 | Alpha Biopharma | Series B | 25M |
| 8/2018 | ANXIN | Series B | 19.1M |
| 3/2016 | Seven Kilometers | Series A | 5M |
| 2/2019 | Zuiyou | Series C | 80M |
| 7/2008 | Tigermed | Series A | 6.3M |
| 7/2017 | Sino Biological | Series A | 29.4M |
| 12/2014 | SequoiaDB | Series A | 10M |
| 3/2014 | Sanyou Medical | Series A | - |
| 3/2019 | LuPu Investment | Series A | 44.6M |
| 12/2014 | Luoji Siwei | Series A | - |
| 6/2018 | Pop Game | Seed Round | - |
| 2/2016 | Microtech Medical | Series A | 24.3M |
| 3/2010 | Arrail Dental Clinic | Series A | 20M |
| 8/2021 | Neuro3 Therapeutics | Seed Round | 10M |
| 1/2017 | Qkuts | Seed Round | 1M |
| 4/2018 | Meituan | Venture Round | - |
| 11/2013 | Meitu | Seed Round | 5M |
| 11/2021 | Bioyond Tech | Seed Round | 7.8M |
| 12/2021 | Frontis | Seed Round | 18.4M |
| 4/2020 | Cadent Therapeutics | Series B | 15M |
| 7/2020 | XSKY Data Technology | Series D | 33M |
| 5/2013 | Berry Genomics | Series B | 14.7M |
| 12/2019 | SinoUnited Health Clinic | Series C | 8.1M |
| 7/2016 | SequoiaDB | Series B | 10M |
| 8/2010 | eHi Car Rental | Series C | 70M |
| 2/2020 | InfStones | Series A | 10M |
| 1/2008 | 9DIAMOND | Series A | 9.6M |
| 4/2022 | CIX Technology | Angel Round | - |
| 5/2017 | Wacai.com | Series C | 0 |
| 1/2021 | Vistel | Series B | 9.3M |
| 11/2021 | Platelet BioGenesis | Series B | 75.5M |
| 7/2018 | Madaket | Series B | 0 |
| 6/2006 | Fangtek | Series C | 12M |
| 1/2015 | Bilibili | Series B | 44.2M |
| 7/2015 | Zhaolu Tianxia Wang | Series B | 3.2M |
| 7/2017 | Akulaku | Series B | 24.8M |
| 12/2020 | WT Microtech Medical | Series D | 0 |
| 1/2015 | Zhaosuliao | Series A | 20M |
| 12/2015 | HyperStrong | Series A | 20.3M |
| 7/2015 | Wacai.com | Series B | 80M |
| 4/2016 | ACEA BIO | Series E | 6M |
| 9/2019 | Amphivena Therapeutics | Series C | 0 |
| 3/2013 | Origene Technologies | Series C | 21.3M |
| 6/2014 | MOGU | Series D | 200M |
| 5/2014 | Crown Bioscience | Series D | 26.6M |
| 8/2020 | Connect Biopharmaceuticals | Series C | 115M |
| 4/2021 | Gaugene | Series A | 4.6M |
| 9/2021 | XellSmart | Seed Round | 11.9M |
| 1/2023 | Biotree | Series A | - |
| 11/2011 | Zhihu | Series A | 8M |
| 2/2017 | Ark Biosciences | Series A | 8M |
| 6/2018 | Ark Biosciences | Series B | 32M |
| 3/2015 | Mafengwo | Series C | 100M |
| 1/2017 | Zhihu | Series D | 103.3M |
| 4/2019 | Coffee Box | Series B | 30.6M |
| 11/2018 | WorkTrans | Series B | 23M |
| 7/2018 | Moretickets | Series C | 61.7M |
| 10/2019 | dMed | Series B | 50M |
| 8/2021 | Matrixport | Series C | 0 |
| 8/2013 | Shenogen Pharma Group | Series C | 20M |
| 1/2021 | WeRide | Series B | 0 |
| 1/2022 | EigenCOMM | Series C | 157.3M |
| 9/2019 | DST Car | Venture Round | 30M |
| 1/2019 | NASN Automotive Electronics | Series B | 59.6M |
| 5/2021 | Valgen Medtech | Series B | 188M |
| 5/2019 | ZuzuChe | Series C | 26.1M |
| 7/2011 | Fanli | Series A | 10M |
| 9/2008 | ChinaCache | Series C | - |
| 4/2008 | Nurien Software | Series A | 15M |
| 11/2015 | ACEA BIO | Venture Round | 30M |
| 12/2016 | WT Microtech Medical | Series B | - |
| 4/2016 | Insta360 | Series B | - |
| 9/2019 | Insilico Medicine | Series B | 37M |
| 3/2019 | Abbisko Therapeutics | Series B | 42M |
| 5/2016 | Bilibili | Series C | 199.3M |
| 5/2016 | Musical.ly | Series C | 133.5M |
| 9/2020 | InventisBio | Series D | 0 |
| 7/2022 | Ark Biosciences | Series D | - |
| 7/2011 | Xiaomi | Series A | 41M |
| 12/2011 | Xiaomi | Series B | 90M |
| 7/2011 | VANCL | Series F | 230M |
| 10/2021 | Clounix | Angel Round | - |
| 11/2017 | Twine Health | Series A | 1.5M |
| 5/2017 | Sinocelltech | Series A | 29M |
| 12/2014 | Meitu | Series C | 190M |
| 4/2021 | Axera | Seed Round | - |
| 7/2015 | Tiebaobei | Series B | 16.2M |
| 11/2013 | Tiebaobei | Series A | - |
| 11/2021 | GenEdit | Angel Round | 9M |
| 11/2019 | Genius | Series B | 14.2M |
| 4/2021 | Abogen Biosciences | Series B | 91.6M |
| 7/2021 | Petkit | Series D | 60M |
| 2/2019 | Petkit | Series C | 20M |
| 9/2020 | Petkit | Series C | - |
| 1/2022 | Zhenge Biotech | Series C | 100M |
| 2/2014 | ITutorGroup | Series B | 100M |
| 10/2015 | CANbridge Pharmaceuticals | Series A | 10M |
| 3/2018 | LetsGetChecked | Series A | 12M |
| 6/2021 | Hesai Technology | Series D | 300M |
| 2/2023 | Oricell Therapeutics | Series B | 0 |
| 4/2019 | Structure Therapeutics | Series A | 16M |
| 6/2009 | Novast | Series B | 25M |
| 8/2019 | MyHealthTeams | Series B | 0 |
| 1/2019 | Antengene Corporation | Series B | 0 |
| 1/2009 | Nurien Software | Series A | 10M |
| 6/2012 | Xiaomi | Series C | 216M |
| 3/2023 | TandemAI | Series A | 0 |
| 7/2022 | Gaugene | Series B | 0 |
| 6/2017 | Zai Lab | Series C | 30M |
| 7/2017 | Kezar Life Sciences | Series B | 0 |
| 8/2021 | Abogen Biosciences | Series C | 0 |
| 1/2021 | Abbisko Therapeutics | Series D | 123M |
| 2/2022 | GluBio Therapeutics | Series A | 0 |
| 11/2015 | CanSinoBIO | Series C | 30M |
| 10/2021 | Structure Therapeutics | Series B | 0 |
| 2/2017 | Jacobio Pharmaceuticals | Series B | - |
| 4/2023 | Bioyond Tech | Series A | 0 |
| 9/2022 | XellSmart | Series A | - |
| 9/2018 | SequoiaDB | Series C | 0 |
| 1/2019 | Schrödinger | Series E | 0 |
| 8/2022 | OriginCell | Series B | 0 |
| 12/2017 | Tiebaobei | Series C | - |
| 12/2019 | OriginCell | Series A | 7.1M |
| 3/2020 | Abbisko Therapeutics | Series C | 70M |
| 11/2018 | Genor Biopharma | Venture Round | 276.7M |
| 12/2016 | Shulan Health | Series B | 31.2M |
| 1/2023 | Singular Medical | Series B | - |
| 8/2017 | New Horizon Health | Series B | 20M |
| 12/2019 | Clinflash Heathcare Technology | Series A | 4.3M |
| 2/2021 | Liangyihui | Series C | 0 |
| 3/2020 | Xueba100.com | Convertible Note | 22.7M |
| 3/2021 | IntoCare | Secondary Market | 4.3M |
| 1/2010 | YPX Cayman Holdings | Series A | 10M |
| 12/2016 | Finern | Series A | 7.3M |
| 9/2019 | Hesai Technology | Series C | 1.1M |
| 10/2008 | T4GAME | Series A | 3M |
| 12/2018 | Xiudan | Seed Round | 3M |
| 3/2020 | ShouTi | Series A | 26M |
| 6/2015 | Cehome | Series B | 2.5M |
| 1/2016 | HyperStrong | Series B | 68.5M |
| 5/2014 | Broncus Technologies | Venture Round | 4.3M |
| 5/2018 | Bang Er Orthopedic | Series C | 15.8M |
| 6/2021 | BrainHealth | Series C | 72.4M |
| 3/2015 | Bioon.com | Series A | 2.9M |
| 2/2021 | Wholee | Series A | 10k |
| 12/2021 | Clinflash Heathcare Technology | Venture Round | 15.5M |
| 4/2018 | KangBai | Series A | 3.7M |
| 8/2021 | Yunqi | Seed Round | 31M |
| 3/2021 | Basecamp Bio | Angel Round | 14M |
| 6/2022 | Insilico Medicine | Series D | 0 |
| 5/2019 | Zaojiu | Venture Round | 2M |
| 7/2013 | Hortor | Series A | 2.5M |
| 12/2021 | Sinogen Biopharma | Venture Round | 3M |
| 11/2018 | Mucho Indonesia | Seed Round | 3M |
| 9/2021 | ROX Motor | Series B | 60M |
| 12/2011 | Beijing GoodWill Technology | Series A | 4.2M |
| 5/2017 | DST Car | Seed Round | 7.3M |
| 12/2019 | Inbilin | Venture Round | - |
| 11/2018 | Webuy Group | Series B | 15.8M |
| 8/2016 | Xiutao | Seed Round | 1.5M |
| 10/2015 | Wuxi Vision Pro | Series A | 4.8M |
| 11/2018 | WebComics | Seed Round | 3.2M |
| 8/2021 | Lingyi Zhihui | Series B | 0 |
| 9/2019 | Plum | Series B | 0 |
| 9/2018 | Aohua | Series D | 43.7M |
| 3/2018 | V Light | Seed Round | 1M |
| 1/2016 | Aohua | Series C | 30.8M |
| 4/2022 | Rhino Health | Venture Round | 5.7M |
| 7/2015 | Lanmi | Series A | 5M |
| 6/2013 | VINNO Technology | Series A | 5.8M |
| 8/2017 | Antengene Corporation | Series A | 21M |
| 2/2017 | Anxin Doctor | Series B | 29.1M |
| 7/2010 | Sangon Biotech | Series A | 6.2M |
| 7/2020 | New Horizon Health | Series E | 30M |
| 7/2018 | dMed | Series B | 6M |
| 1/2020 | Chushou | Debt Financing | 4M |
| 3/2019 | ACEA BIO | Venture Round | 20M |
| 1/2018 | Chushou | Series D | 47.5M |
| 2/2017 | Anssure Pharma | Series A | 8.7M |
| 4/2020 | Belief Biomed | Series B | 84M |
| 3/2008 | Touchmedia | Series B | 14.2M |
| 9/2017 | VR Medical | Series B | 3M |
| 2/2021 | Saints Sages Medical | Series A | 18.6M |
| 3/2015 | Insta360 | Series A | 8M |
| 11/2021 | Micropace | Series A | 5.5M |
| 9/2019 | Tisenc | Series B | 11.2M |
| 8/2006 | Touchmedia | Series A | - |
| 4/2021 | Unisound | Series D | 60M |
| 1/2005 | Gammastar Medical Group | Series A | 8.7M |
| 8/2018 | APT Medical | Series B | 11.1M |
| 5/2010 | ChinaCache | Post-IPO Equity | - |
| 8/2018 | Cool Math | Series A | 10M |
| 5/2021 | IntoCare | Series D | 43.2M |
| 5/2021 | Data Transmission Group | Secondary Market | 9.3M |
| 12/2013 | Shanghai Rendu Biotechnology | Series B | 10.3M |
| 12/2017 | Cehome | Series D | 44M |
| 10/2013 | Dajiabao | Series A | - |
| 8/2022 | Oricell Therapeutics | Series B | 120M |
| 11/2021 | Beijing Okeanos Technology | Series B | 22.4M |
| 8/2021 | Superhexa | Seed Round | 9.9M |
| 12/2021 | Superhexa | Series A | 28M |
| 9/2007 | Juren Educational | Venture Round | 20M |
| 10/2017 | SGEET | Series A | 7.5M |
| 12/2019 | Yuanxin Huibao | Series A | 4.3M |
| 5/2014 | Meitu | Series B | 115M |
| 7/2018 | ZEGOCLOUD | Series B | 16M |
| 5/2021 | MeetFuture China | Series A | 12.3M |
| 8/2017 | Kintep Environmental | Series B | 5.6M |
| 6/2011 | Novast | Series C | 2.9M |
| 5/2013 | Cehome | Series A | 2M |
| 4/2015 | HaiRun Pictures | Series A | 11.3M |
| 1/2021 | Oricell Therapeutics | Series A | 0 |
| 11/2010 | Guokang Health Management | Series B | 14.9M |
| 10/2017 | Gaiya Environment | Series A | 6.1M |
| 1/2021 | RFoneTech | Series A | 4.6M |
| 10/2016 | Broncus Technologies | Series A | 12.2M |
| 8/2019 | Haoyiku | Series C | 100M |
| 12/2017 | Xiaobu | Series B | 14M |
| 4/2015 | Fortune International Factoring | Series A | 16.2M |
| 10/2021 | Clounix | Seed Round | 34.9M |
| 5/2018 | Hanqi | Series A | 6.3M |
| 7/2019 | Chuman | Series B | 8.7M |
| 11/2017 | Chuman | Series A | 8.3M |
| 5/2021 | Render | Series A | 15.5M |
| 9/2011 | Novast | Series D | 2M |
| 12/2011 | Appconomy | Series B | 10M |
| 4/2017 | IntoCare | Series A | 26M |
| 8/2018 | Plum | Series B | 21.4M |
| 12/2021 | InfStones | Series B | 33M |
| 2/2021 | Morewis | Series B | 9.3M |
| 9/2009 | 60DXchange | Venture Round | - |
| 4/2021 | P&a;R Measurement Technology | Series C | 23.9M |
| 6/2017 | SinoTau | Series B | 22M |
| 2/2021 | Singular Medical | Series B | 24M |
| 2/2018 | P&a;R Measurement Technology | Series A | 9.9M |
| 4/2017 | CanSinoBIO | Series E | 0 |
| 7/2010 | LanzaTech | Series B | 18M |
| 12/2019 | Oricell Therapeutics | Seed Round | 14.2M |
| 1/2020 | DST Car | Series C | - |
| 12/2021 | TUNGEE | Series B | 0 |
| 3/2016 | Cehome | Series C | 25M |
| 8/2018 | Kira Pharmaceuticals | Series A | 13M |
| 11/2020 | LaNova Medicines | Series A | 84.4M |
| 3/2020 | Singular Medical | Series A | 10M |
| 10/2018 | DST Car | Series B | 47.4M |
| 3/2022 | MeetFuture China | Series B | 0 |
| 8/2016 | Ruhnn Holding Limited | Series C | - |
| 7/2020 | Antengene Corporation | Series C | 97M |
| 1/2017 | Diandoc | Seed Round | 1M |
| 9/2017 | TigerGraph | Series A | 31M |
| 9/2015 | Oakbarrel | Series B | 3.1M |
| 11/2018 | Eigen | Series B | 6.6M |
| 10/2010 | Dang Le | Series A | 12M |
| 9/2009 | Jiayuan | Series B | - |
| 5/2018 | Xueba100.com | Series D | 22.5M |
| 7/2020 | 52toys | Secondary Market | 2M |
| 2/2017 | LIH Investment &a; Management | Series A | 5.8M |
| 12/2018 | Try Try | Series A | 7M |
| 4/2016 | AirQuality | Series B | 4M |
| 3/2018 | 52toys | Series A | 14.6M |
| 2/2009 | Youxigu | Series A | - |
| 6/2016 | JunHe | Series B | 7.6M |
| 3/2019 | 52toys | Series A | 447.3k |
| 4/2020 | DiNovA Medtech | Series C | 17M |
| 8/2022 | GluBio Therapeutics | Series A | 0 |
| 8/2022 | OriginCell | Series B | 0 |
| 8/2022 | Oricell Therapeutics | Series B | 0 |
| 7/2022 | Chatail | Series B | 0 |
| 7/2022 | CIX Technology | Seed Round | - |
| 7/2022 | Biotree | Series A | 0 |
| 7/2022 | Gaugene | Series B | 0 |
| 7/2022 | Ark Biosciences | Series D | - |
| 6/2022 | LaNova Medicines | Series B | - |
| 6/2022 | Insilico Medicine | Series D | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
